Implications of screening for coexisting transthyretin amyloidosis and aortic stenosis
- 11 October 2021
- Vol. 108 (1), 11-13
- https://doi.org/10.1136/heartjnl-2021-320229
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosisHeart, 2021
- Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac AmyloidosisJournal of Invasive Cardiology, 2020
- Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosisEuropean Journal of Heart Failure, 2020
- Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantationEuropean Heart Journal, 2020
- Light‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcomeEuropean Journal of Heart Failure, 2020
- Aortic Stenosis and Cardiac AmyloidosisJournal of Invasive Cardiology, 2019
- Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacementEuropean Heart Journal, 2017
- Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac AmyloidosisJACC: Cardiovascular Imaging, 2015